m-PEG8-Lys(Mal)-Val-Ala-PAB-Ph-CO-Dazostinag

SKU: orb2664133

Description

This compound is an antibody-drug conjugate (ADC) linker-payload featuring a maleimide group for antibody conjugation, a protease-cleavable Val-Ala dipeptide, and a PAB spacer that releases the cytotoxic Dazostinag agent. It is a key research tool for developing targeted cancer therapies and studying drug delivery mechanisms in both in vitro and in vivo experimental models.

Images & Validation

−

Key Properties

−

CAS Number	2553413-13-9
MW	1779.72
Formula	C₇₄H₉₈F₂N₁₄O₂₇P₂S₂
SMILES	F[C@H]1[C@H](N2C=3C(N=C2)=C(NC(=O)C4=C(CN(C(OCC5=CC=C(NC([C@@H](NC([C@@H](NC([C@H](CCCCN6C(=O)C=CC6=O)NC(CCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O)C(C)C)=O)C)=O)C=C5)=O)C)C=CC=C4)N=CN3)O[C@]7([C@]1(OP(=O)(S)OC[C@]8(O[C@H]([C@](OP(=O)(S)OC7)([C@@H]8O)[H])N9C%10=C(C(F)=C9)C(=O)N=CN%10)[H])[H])[H]
Target	Drug-Linker Conjugates for ADC

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

172419435 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols